Study Suggests Possibility that CETP Inhibitors May Improve Glycemic Control - Larry Husten - Cardiobrief - Forbes
Links shared publicly online about this topic.
- 137total visits
Study Suggests Possibility that CETP Inhibitors May Improve Glycemic Control - Larry Husten - Cardiobrief - Forbes
A new analysis of the ILLUMINATE trial raises the possibility that CETP inhibitors like torcetrapib may have the unexpected beneficial effect of improving glycemic control in addition to their intended effect of raising HDL cholesterol. Development of torceptrapib was halted several years ago following the early termination of the large [...]
View full resource at blogs.forbes.com
Tags: Cholesterol, Drug
Most Recently Shared on July 18, 2011 at 8:32 pm By:
Study Suggests Possibility that CETP Inhibitors May Improve Glycemic Control: A new analysis of the ILL... http://onforb.es/pMKsQI #drug
Advertisement
